Latency Period and Age-Specific Patterns of Pleural Mesothelioma
Pleural mesothelioma develops after a long delay following asbestos exposure. Researchers call this interval the latency period. Most studies place the average between 20 and 50 years. Many reports put the mean near 40 years for pleural disease. Rare cases appear after only 10 years. Others surface after 60 years or more.
The long delay explains why most patients receive a diagnosis in later life. Incidence rises steadily after age 50. Rates then peak between 70 and 80 years. After age 85 the numbers remain high among men. Younger adults under 40 account for only a small fraction of cases. Those early-onset tumours often show different genetic features.
Gender patterns follow exposure history. Men face higher rates because many worked in shipbuilding, construction, mining, and asbestos-product plants. Women more often record environmental or household contact. Age-adjusted figures stay several times greater in males across most registries. However, recent data from some European programmes show the male-to-female ratio slowly narrowing.
Birth-cohort studies reveal further shifts. Younger male cohorts born after the 1920s now show falling incidence. Asbestos bans and workplace controls after the 1970s reduced new occupational contact. Older men continue to record rising or stable rates. Longer life expectancy lets the long latency period play out. Women display flatter trends overall.
India illustrates the same latency problem. Asbestos use remains widespread in construction and industry. Reported mesothelioma numbers stay low. Under-diagnosis and limited occupational surveillance explain much of the gap. Cases that do appear still cluster in older men with decades-old workplace histories.
Latency therefore links past exposure to present disease. Age-specific curves reflect both historical asbestos use and current population ageing. Continued monitoring of older cohorts remains essential. Younger groups already show the benefit of reduced contact. This overview summarises published epidemiological patterns. It does not constitute medical advice.